glp 1 and alcohol consumption GLP-1 Anti-Obesity Rx and Substance Use Disorders GLP-1 & Alcohol: What Happens

If you experience any of these symptoms, contact your healthcare provider immediately to address these concerns

Many regenerative medicine providers use both: PRP for the initial concentrated stimulus, then BPC-157 to sustain the healing environment

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

Hirrlinger J1, Gutterer JM, Kussmaul L, Hamprecht B, Dringen R